Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.
Authors : Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A Year : 2022 Journal : Cells
Bufalin for an innovative therapeutic approach against cancer.
Authors : Soumoy L, Ghanem GE, Saussez S, Journe F Year : 2022 Journal : Pharmacol Res
Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.
Authors : Furgiuele S, Descamps G, Cascarano L, Boucq A, Dubois C, Journe F, Saussez S Year : 2022 Journal : Int J Mol Sci
Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].
Authors : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Salès F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G Year : 2022 Journal : Eur J Cancer
Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.
Authors : Furgiuele S, Descamps G, Lechien JR, Dequanter D, Journe F, Saussez S Year : 2022 Journal : Cells